- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05282732
Retrospective Analysis of Performance and Treatment Data Collected for Genius SleddFlux Filter, Ultraflux AV 600 S Filter & Genius 90 Concentrates in Haemodialysis Patients (Genius)
February 22, 2024 updated by: Fresenius Medical Care Deutschland GmbH
Retrospective Analysis of Performance and Treatment Data Collected for Genius SleddFlux Filter, Ultraflux AV 600 S Filter & Genius 90 Concentrates in Acute Haemodialysis, Haemodynamically Instable Patients and Chronic Haemodialysis Patients
Retrospective analysis of performance and treatment data collected for Genius SleddFlux Filter, Ultraflux AV 600 S Filter & Genius 90 Concentrates in acute haemodialysis, haemodynamically instable patients and chronic haemodialysis patients
- to analyse performance and treatment data from patients treated with the investigational device
- to evaluate the filter characteristics for aHD (Acute haemodialysis) patients
- to evaluate the improvement of kidney function for aHD patients
Study Overview
Status
Recruiting
Study Type
Observational
Enrollment (Estimated)
100
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Tatiana De los Rios
- Phone Number: +49 6172 608 2362
- Email: Tatiana.De-Los-Rios@fmc-ag.com
Study Contact Backup
- Name: Jana Schmitt
- Phone Number: +49 6172 609 95403
- Email: Jana.Schmitt@fmc-ag.com
Study Locations
-
-
-
Hannover, Germany, 30625
- Recruiting
- Medizinische Hochschule Hannover
-
Contact:
- Bernhard Schmidt, Prof.Dr.
- Email: Schmidt.Bernhard@mh-hannover.de
-
Jena, Germany, 07743
- Recruiting
- Universitätsklinikum Jena
-
Contact:
- Brauer Martin, Dr.
- Email: martin.brauer@med.uni-jena.de
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
N/A
Sampling Method
Non-Probability Sample
Study Population
Haemodynamically instable patients in acute haemodialysis and chronic haemodialysis patients treatment with the Genius system
Description
Inclusion Criteria:
- All patients with an indication for the extracorporeal blood treatment suffering from renal insufficiency who received all treatments, between January 2019 and December 2019, with the investigational devices have to be included in the study in chronological order.
- For aHD patients: availability of at least 3 of the 5 primary variables (daily urea, creatinine, potassium, ultrafiltration and effluent volume) for 50 % of the documented treatments.
- For cHD patients: availability of the ultrafiltration values for all treatments and at least one value for urea and creatinine per week
Exclusion Criteria:
- Simultaneous use of another filter/adsorber for another form of therapy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
aHD: Acute haemodialysis patients
|
cHD: Chronic haemodialysis patients
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Daily values for urea, Unit: mg/dl or mmol/L
Time Frame: During the intervention
|
Acute haemodialysis patients
|
During the intervention
|
Daily values for creatinine, Unit: mg/dl or mmol/ or µmol/L
Time Frame: During the intervention
|
Acute haemodialysis patients
|
During the intervention
|
Daily values for potassium, Unit: mg/dl or mmol/ or µmol/L
Time Frame: During the intervention
|
Acute haemodialysis patients
|
During the intervention
|
Ultrafiltration volume (UF) and Effluent volume (per treatment)
Time Frame: During the intervention
|
Acute haemodialysis patients
|
During the intervention
|
Values for urea and creatinine (measured according to the clinical practice of the site)
Time Frame: During the intervention
|
Chronic haemodialysis patients
|
During the intervention
|
Planned and delivered UF-volume (per treatment)
Time Frame: During the intervention
|
Chronic haemodialysis patients
|
During the intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Martin Brauer, Dr. med., Universitätsklinikum Jena
- Principal Investigator: Bernhard Schmidt, Prof Dr med, Hannover Medical School
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 7, 2022
Primary Completion (Estimated)
December 1, 2024
Study Completion (Estimated)
December 1, 2024
Study Registration Dates
First Submitted
February 16, 2022
First Submitted That Met QC Criteria
March 7, 2022
First Posted (Actual)
March 16, 2022
Study Record Updates
Last Update Posted (Estimated)
February 23, 2024
Last Update Submitted That Met QC Criteria
February 22, 2024
Last Verified
February 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pathologic Processes
- Kidney Diseases
- Urologic Diseases
- Disease Attributes
- Renal Insufficiency, Chronic
- Chronic Disease
- Female Urogenital Diseases
- Female Urogenital Diseases and Pregnancy Complications
- Urogenital Diseases
- Male Urogenital Diseases
- Kidney Failure, Chronic
- Renal Insufficiency
- Acute Kidney Injury
Other Study ID Numbers
- Genius-AKI-01-D
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Renal Failure
-
University of Sao Paulo General HospitalUnknownRenal Transplant Rejection | Graft Failure | Transplant; Failure, Kidney | Chronic Renal Failure (CRF)Brazil
-
Rockwell Medical Technologies, Inc.CompletedRenal Failure Chronic Requiring HemodialysisUnited States, Puerto Rico
-
Rockwell Medical Technologies, Inc.CompletedRenal Failure Chronic Requiring HemodialysisUnited States, Canada
-
Angiodynamics, Inc.TerminatedChronic Kidney Disease | Acute Kidney Injury | Acute Renal Failure | Renal Failure Chronic Contrast InducedUnited States
-
University Hospital, Clermont-FerrandRecruitingAcute Kidney Injury | Transient Acute Renal Failure | Persistent Acute Renal FailureFrance
-
University Hospital, GhentCompletedAcute Renal Failure | Chronic Renal FailureBelgium
-
The University of Hong KongHospital Authority, Hong KongCompletedEnd-stage Renal Failure (ESRF)Hong Kong
-
Washington University School of MedicineCompletedAcute Renal Failure | Chronic Renal FailureUnited States
-
The Hong Kong Polytechnic UniversityHospital Authority, Hong KongCompletedPalliative Care | Renal Failure, End-stageHong Kong
-
PfizerCompletedChronic Renal Failure Requiring HemodialysisUnited States, Puerto Rico